Victorio Jauregui-Matos

Mr. Victorio Jauregui-Matos

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
EDErin E Doherty
Erin E Doherty
AKAgya Karki
Agya Karki
XWXander E Wilcox
Xander E Wilcox
HMHerra Grajo Mendoza
Herra Grajo Mendoza
AMAashrita Manjunath
Aashrita Manjunath
PBPeter Beal
Peter Beal
ADARs (adenosine deaminases acting on RNA) can be directed to sites in the transcriptome by complementary guide strands allowing for the correction of disease-causing mutations at the RNA level. However, ADARs show bias against editing adenosines with a guanosine 5′ nearest neighbor (5′-GA sites), limiting the scope of this approach. Earlier studies suggested this effect arises from a clash in the RNA minor groove involving the 2-amino group of the guanosine adjacent to an editing site. Here we show that nucleosides capable of pairing with guanosine in a syn conformation enhance editing for 5′-GA sites. We describe the crystal structure of a fragment of human ADAR2 bound to RNA bearing a G:G pair adjacent to an editing site. The two guanosines form a Gsyn:Ganti pair solving the steric problem by flipping the 2-amino group of the guanosine adjacent to the editing site into the major groove. Also, duplexes with 2′-deoxyadenosine and 3-deaza-2′-deoxyadenosine displayed increased editing efficiency, suggesting the formation of a Gsyn:AH+anti pair. This was supported by X-ray crystallography of an ADAR complex with RNA bearing a G:3-deaza dA pair. This study shows how non-Watson–Crick pairing in duplex RNA can facilitate ADAR editing enabling the design of next generation guide strands for therapeutic RNA editing.

3 June 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
VJVictorio Jauregui-Matos
Victorio Jauregui-Matos
OJOlivia Jacobs
Olivia Jacobs
RORandall Ouye
Randall Ouye
SMSukanya Mozumder
Sukanya Mozumder
PSPrince J Salvador
Prince J Salvador
PBPeter Beal
Peter Beal
Adenosine Deaminases Acting on RNA (ADARs) are enzymes that catalyze the conversion of adenosine to inosine in RNA duplexes. These enzymes can be harnessed to correct disease-causing G-to-A mutations in the transcriptome because inosine is translated as guanosine. Guide RNAs (gRNAs) can be used to direct the ADAR reaction to specific sites. Chemical modification of ADAR guide strands is required to facilitate delivery, increase metabolic stability, and increase the efficiency and selectivity of the editing reaction. Here, we show the ADAR reaction is highly sensitive to ribose modifications (e.g. 4′-C-methylation and Locked Nucleic Acid (LNA) substitution) at specific positions within the guide strand. Our studies were enabled by the synthesis of RNA containing a new, ribose-modified nucleoside analog (4′-C-methyladenosine). Importantly, the ADAR reaction is potently inhibited by LNA or 4′-C-methylation at different positions in the ADAR guide. While LNA at guide strand positions −1 and −2 block the ADAR reaction, 4′-C-methylation only inhibits at the −2 position. These effects are rationalized using high-resolution structures of ADAR-RNA complexes. This work sheds additional light on the mechanism of ADAR deamination and aids in the design of highly selective ADAR guide strands for therapeutic editing using chemically modified RNA.

31 October 2022 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
HBHannah Faith Brinkman
Hannah Faith Brinkman
VJVictorio Jauregui-Matos
Victorio Jauregui-Matos
HMHerra Grajo Mendoza
Herra Grajo Mendoza
EDErin E. Doherty
Erin E. Doherty
PBPeter Beal
Peter Beal
Adenosine deaminases acting on RNAs (ADARs) can be directed to correct RNA mutations with complementary guide strands. We introduce nucleoside analogs at the −1 position of the guide RNA to enhance target editing and decrease off-target editing.

29 September 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
AMAashrita Manjunath
Aashrita Manjunath
JCJeff Cheng
Jeff Cheng
KCKristen B Campbell
Kristen B Campbell
CJCasey Jacobsen
Casey Jacobsen
HMHerra Grajo Mendoza
Herra Grajo Mendoza
PBPeter Beal
Peter Beal
Adenosine Deaminases Acting on RNA (ADARs) are members of a family of RNA editing enzymes that catalyze the conversion of adenosine into inosine in double-stranded RNA (dsRNA). ADARs’ selective activity on dsRNA presents the ability to correct mutations at the transcriptome level using guiding oligonucleotides. However, this approach is limited by ADARs’ preference for specific sequence contexts to achieve efficient editing. Substrates with a guanosine adjacent to the target adenosine in the 5′ direction (5′-GA) are edited less efficiently compared to substrates with any other canonical nucleotides at this position. Previous studies showed that a G/purine mismatch at this position results in more efficient editing than a canonical G/C pair. Herein, we investigate a series of modified oligonucleotides containing purine or size-expanded nucleoside analogs on guide strands opposite the 5′-G (−1 position). The results demonstrate that modified adenosine and inosine analogs enhance editing at 5′-GA sites. Additionally, the inclusion of a size-expanded cytidine analog at this position improves editing over a control guide bearing cytidine. High-resolution crystal structures of ADAR:/RNA substrate complexes reveal the manner by which both inosine and size-expanded cytidine are capable of activating editing at 5′-GA sites. Further modification of these altered guide sequences for metabolic stability in human cells demonstrates that the incorporation of specific purine analogs at the −1 position significantly improves editing at 5′-GA sites.

23 October 2025 in ACS Chemical Biology
Verified
Journal Article
Closed access
VJVictorio Jauregui-Matos
Victorio Jauregui-Matos
DDDhrubajyoti Datta
Dhrubajyoti Datta
JKJayanta Kundu
Jayanta Kundu
VKVathan Kumar
Vathan Kumar
JHJoel M. Harp
Joel M. Harp
MMMuthiah Manoharan
Muthiah Manoharan

21 November 2025 in ChemBioChem
Verified
Journal Article
Closed access
PSPrince J. Salvador
Prince J. Salvador
SLSherry Lin
Sherry Lin
MCMegan M. Chinn
Megan M. Chinn
VJVictorio Jauregui-Matos
Victorio Jauregui-Matos
AMAashrita Manjunath
Aashrita Manjunath
PBPeter Beal
Peter Beal